CVE-2002-0855
UnknownEPSS 6.11%
Last modified
CVE-2002-0855 is a vulnerability of currently unknown severity. Cross-site scripting vulnerability in Mailman before 2.0.12 allows remote attackers to execute script as other users via a subscriber's list subscription options in the (1) adminpw or (2) info parameters to the ml-name feature.. EPSS estimates a 6.11% chance of exploitation in the next 30 days.
Description
Cross-site scripting vulnerability in Mailman before 2.0.12 allows remote attackers to execute script as other users via a subscriber's list subscription options in the (1) adminpw or (2) info parameters to the ml-name feature.
Metrics
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Gnu | Mailman | 2.0.12 |
References
- http://mail.python.org/pipermail/mailman-announce/2002-July/000043.htmlPatch, Vendor Advisory
- http://www.iss.net/security_center/static/9985.phpVendor Advisory
- http://www.securityfocus.com/bid/5298Exploit, Patch, Vendor Advisory
- http://mail.python.org/pipermail/mailman-announce/2002-July/000043.htmlPatch, Vendor Advisory
- http://www.iss.net/security_center/static/9985.phpVendor Advisory
- http://www.securityfocus.com/bid/5298Exploit, Patch, Vendor Advisory
Timeline
- Published
- Last Modified
- Status
- Modified
Frequently Asked Questions
What is CVE-2002-0855?
Cross-site scripting vulnerability in Mailman before 2.0.12 allows remote attackers to execute script as other users via a subscriber's list subscription options in the (1) adminpw or (2) info parameters to the ml-name feature.
How severe is CVE-2002-0855?
Severity scoring for CVE-2002-0855 is pending analysis. The EPSS model estimates a 6.11% probability of exploitation in the next 30 days.
How do I fix CVE-2002-0855?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.
Are you affected by CVE-2002-0855?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST